首页> 外国专利> NOVEL ENTEROCOCCUS FAECALIS CRNB-A3 STRAIN WITH A GINSENG FERMENTATION ABILITY AND A METHOD FOR CONVERTING SAPONIN USING THE SAME

NOVEL ENTEROCOCCUS FAECALIS CRNB-A3 STRAIN WITH A GINSENG FERMENTATION ABILITY AND A METHOD FOR CONVERTING SAPONIN USING THE SAME

机译:具有人参发酵能力的新型肠球菌粪便CRNB-A3菌株和使用相同菌株转化皂苷的方法

摘要

PURPOSE: A novel Enterococcus faecalis CRNB-A3(KCTC 11930 BP) strain with saponin decomposition ability is provided to prepare ginseng and red ginseng fermentations with new efficacy.;CONSTITUTION: An Enterococcus faecalis CRNB-A3(KCTC 11930 BP) strain has a saponin converting ability. Saponin Rb2 is converted into other ginsenoside using the strain. Ginseng is fermented by inserting the strain and fermenting at 20-50 Deg. C. for 20-120 hours. A health functional food contains the fermented ginseng as a raw material. The health functional food is manufactured in the form of a liquid phase formulation, candy, gum, paste, snack, and powder. A pharmaceutical composition for preventing or treating inflammation, allergy, cancer, impotency, hypertension, hyperlipidemia, thrombosis, and aging contains the fermented ginseng.;COPYRIGHT KIPO 2013
机译:目的:提供一种新型的具有皂苷分解能力的粪肠球菌CRNB-A3(KCTC 11930 BP)菌株,以制备具有新功效的人参和红参发酵液。;组成:粪肠球菌CRNB-A3(KCTC 11930 BP)菌株具有皂苷。转换能力。用该菌株将皂苷Rb2转化为其他人参皂苷。通过插入菌株将人参发酵,并在20-50度下发酵。 C.持续20-120小时。一种保健功能食品,包含发酵人参作为原料。保健功能食品以液相制剂,糖果,口香糖,糊剂,点心和粉剂的形式生产。用于预防或治疗炎症,过敏,癌症,阳imp,高血压,高脂血症,血栓形成和衰老的药物组合物,其中含有发酵人参。; COPYRIGHT KIPO 2013

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号